<code id='98BDD0F468'></code><style id='98BDD0F468'></style>
    • <acronym id='98BDD0F468'></acronym>
      <center id='98BDD0F468'><center id='98BDD0F468'><tfoot id='98BDD0F468'></tfoot></center><abbr id='98BDD0F468'><dir id='98BDD0F468'><tfoot id='98BDD0F468'></tfoot><noframes id='98BDD0F468'>

    • <optgroup id='98BDD0F468'><strike id='98BDD0F468'><sup id='98BDD0F468'></sup></strike><code id='98BDD0F468'></code></optgroup>
        1. <b id='98BDD0F468'><label id='98BDD0F468'><select id='98BDD0F468'><dt id='98BDD0F468'><span id='98BDD0F468'></span></dt></select></label></b><u id='98BDD0F468'></u>
          <i id='98BDD0F468'><strike id='98BDD0F468'><tt id='98BDD0F468'><pre id='98BDD0F468'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:93
          Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT
          Adobe

          Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

          The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

          advertisement

          The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Cognito secures funding to test medical device for Alzheimer's
          Cognito secures funding to test medical device for Alzheimer's

          AdobeJustasanewwaveofapproveddrugsforAlzheimer’sdiseasereachespatients,medicaldevicecompanyCognitoTh

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          The lessons of Aduhelm, an Alzheimer's drug that was not to be

          StevenSenn/APAduhelm,apioneeringtreatmentforAlzheimer’sdiseasethatcollapsedundercorporatemistakesand